BioSense Global, LLC
Industry
- Biotechnology
- Pharmaceuticals
- Vaccines
See more in Biomedtracker
Latest on BioSense Global, LLC
Scrip
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, and Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . BioDelivery Gains US Rights
In Vivo
IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants
Scrip
• By Joseph Haas and Ian Haydock
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred between Feb. 15 and M